Adjuvant chemotherapy for resected colon cancer: comparison of the prognostic value of tumour and patient related factors

被引：0
|
作者：
Campbell Roxburgh
Alec McDonald
Jonathan Salmond
Karin Oien
John Anderson
Ruth McKee
Paul Horgan
Donald McMillan
机构：
[1] Glasgow Royal Infirmary,University Department of Surgery
[2] Beatson Oncology Centre,Department of Pathology
[3] Glasgow Royal Infirmary,Cancer Research UK, Centre for Oncology and Applied Pharmacology, Division of Cancer Sciences and Molecular Pathology
[4] University of Glasgow,undefined
来源：
International Journal of Colorectal Disease | 2011年 / 26卷
关键词：
Colon cancer; Survival; Inflammation; Numeracy; Adjuvant chemotherapy; Glasgow Prognostic Score;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：483 / 492
页数：9
相关论文
共 50 条
  • [31] Adjuvant chemotherapy of colon cancer current strategies
    Barone, Carlo
    EJC SUPPLEMENTS, 2008, 6 (14): : 60 - 63
  • [32] Adjuvant Chemotherapy for Stage III Colon Cancer
    Taieb, Julien
    Gallois, Claire
    CANCERS, 2020, 12 (09) : 1 - 17
  • [33] Predictive and prognostic value of MSI phenotype in adjuvant colon cancer: Who and how to treat?
    Zaanan, Aziz
    Taieb, Julien
    BULLETIN DU CANCER, 2019, 106 (02) : 129 - 136
  • [34] Adjuvant Chemotherapy in Older Adults With Colon Cancer
    Williams, Grant R.
    Sanoff, Hanna K.
    AMERICAN JOURNAL OF HEMATOLOGY-ONCOLOGY, 2015, 11 (03) : 5 - 10
  • [35] CDX2 prognostic value in stage II/III resected colon cancer is related to CMS classification
    Pilati, C.
    Taieb, J.
    Balogoun, R.
    Marisa, L.
    de Reynies, A.
    Laurent-Puig, P.
    ANNALS OF ONCOLOGY, 2017, 28 (05) : 1032 - 1035
  • [36] Adjuvant chemotherapy in the treatment of colon cancer: randomized multicenter trial of the Italian National Intergroup of Adjuvant Chemotherapy in Colon Cancer (INTACC)
    Di Costanzo, F
    Sobrero, A
    Gasperoni, S
    Dogliotti, L
    Frassineti, L
    Falcone, A
    Lionetto, R
    Bruzzi, P
    Luppi, G
    Gallo, L
    Conte, P
    Comandone, A
    Turci, D
    Marzola, M
    Folco, U
    Pfanner, E
    Mestriner, M
    Boni, C
    Galli, C
    Tonato, M
    Rosso, R
    ANNALS OF ONCOLOGY, 2003, 14 (09) : 1365 - 1372
  • [37] Efficacy of Adjuvant Chemotherapy and Prognostic Factors for Patients with Extrahepatic Bile Duct Cancer
    Lee, Hee Seung
    Lee, Sang Hoon
    Roh, Yun Ho
    Chung, Moon Jae
    Park, Jeong Youp
    Park, Seung Woo
    Song, Si Young
    Chung, Jae Bok
    Bang, Seungmin
    CHEMOTHERAPY, 2015, 61 (03) : 152 - 158
  • [38] Prognostic Value of Methylator Phenotype in Stage III Colon Cancer Treated with Oxaliplatin-based Adjuvant Chemotherapy
    Gallois, Claire
    Taieb, Julien
    Le Corre, Delphine
    Le Malicot, Karine
    Tabernero, Josep
    Mulot, Claire
    Seitz, Jean-Francois
    Aparicio, Thomas
    Folprecht, Gunnar
    Lepage, Come
    Mini, Enrico
    Van Laethem, Jean-Luc
    Emile, Jean-Francois
    Laurent-Puig, Pierre
    CLINICAL CANCER RESEARCH, 2018, 24 (19) : 4745 - 4753
  • [39] Update of Adjuvant Chemotherapy for Resected Gastric Cancer
    Oh, Sang Cheul
    JOURNAL OF GASTRIC CANCER, 2012, 12 (01) : 3 - 6
  • [40] Perineural Invasion Is a Strong Prognostic Factor but Not a Predictive Factor of Response to Adjuvant Chemotherapy in Node-Negative Colon Cancer
    Tu, Junhao
    Yao, Zongxi
    Wu, Wenqing
    Ju, Jianxiang
    Xu, Yinkai
    Liu, Yulin
    FRONTIERS IN ONCOLOGY, 2021, 11
12345